BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 37928542)

  • 1. Features of the TCR repertoire associate with patients' clinical and molecular characteristics in acute myeloid leukemia.
    Pospiech M; Tamizharasan M; Wei YC; Kumar AMS; Lou M; Milstein J; Alachkar H
    Front Immunol; 2023; 14():1236514. PubMed ID: 37928542
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Quantitative characterization of T-cell repertoire in allogeneic hematopoietic stem cell transplant recipients.
    Yew PY; Alachkar H; Yamaguchi R; Kiyotani K; Fang H; Yap KL; Liu HT; Wickrema A; Artz A; van Besien K; Imoto S; Miyano S; Bishop MR; Stock W; Nakamura Y
    Bone Marrow Transplant; 2015 Sep; 50(9):1227-34. PubMed ID: 26052909
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Analysis of the Whole CDR3 T Cell Receptor Repertoire after Hematopoietic Stem Cell Transplantation in 2 Clinical Cohorts.
    Shah O; Tamaresis JS; Kenyon LJ; Xu L; Zheng P; Gupta P; Rangarajan K; Lee S; Spellman S; Nikiforow S; Zehnder J; Meyer EH
    Biol Blood Marrow Transplant; 2020 Jun; 26(6):1050-1070. PubMed ID: 32081787
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Optimization of universal allogeneic CAR-T cells combining CRISPR and transposon-based technologies for treatment of acute myeloid leukemia.
    Calviño C; Ceballos C; Alfonso A; Jauregui P; Calleja-Cervantes ME; San Martin-Uriz P; Rodriguez-Marquez P; Martin-Mallo A; Iglesias E; Abizanda G; Rodriguez-Diaz S; Martinez-Turrillas R; Illarramendi J; Viguria MC; Redondo M; Rifon J; Villar S; Lasarte JJ; Inoges S; Lopez-Diaz de Cerio A; Hernaez M; Prosper F; Rodriguez-Madoz JR
    Front Immunol; 2023; 14():1270843. PubMed ID: 37795087
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Donor T-Cell Repertoire Profiling in Recipient Lymphoid and Parenchyma Organs Reveals GVHD Pathogenesis at Clonal Levels After Bone Marrow Transplantation in Mice.
    Wu Y; Fu J; Wang H; Yu XZ
    Front Immunol; 2021; 12():778996. PubMed ID: 34950143
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combining CRISPR-Cas9 and TCR exchange to generate a safe and efficient cord blood-derived T cell product for pediatric relapsed AML.
    Lo Presti V; Meringa A; Dunnebach E; van Velzen A; Moreira AV; Stam RW; Kotecha RS; Krippner-Heidenreich A; Heidenreich OT; Plantinga M; Cornel A; Sebestyen Z; Kuball J; van Til NP; Nierkens S
    J Immunother Cancer; 2024 Apr; 12(4):. PubMed ID: 38580329
    [TBL] [Abstract][Full Text] [Related]  

  • 7. WT1-specific TCRs directed against newly identified peptides install antitumor reactivity against acute myeloid leukemia and ovarian carcinoma.
    van Amerongen RA; Hagedoorn RS; Remst DFG; Assendelft DC; van der Steen DM; Wouters AK; van de Meent M; Kester MGD; de Ru AH; Griffioen M; van Veelen PA; Falkenburg JHF; Heemskerk MHM
    J Immunother Cancer; 2022 Jun; 10(6):. PubMed ID: 35728869
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Deep-sequencing of the T-cell receptor repertoire in patients with haplo-cord and matched-donor transplants.
    Alachkar H; Nakamura Y
    Chimerism; 2015 Jul; 6(3):47-9. PubMed ID: 26745665
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CRISPR-based gene disruption and integration of high-avidity, WT1-specific T cell receptors improve antitumor T cell function.
    Ruggiero E; Carnevale E; Prodeus A; Magnani ZI; Camisa B; Merelli I; Politano C; Stasi L; Potenza A; Cianciotti BC; Manfredi F; Di Bono M; Vago L; Tassara M; Mastaglio S; Ponzoni M; Sanvito F; Liu D; Balwani I; Galli R; Genua M; Ostuni R; Doglio M; O'Connell D; Dutta I; Yazinski SA; McKee M; Arredouani MS; Schultes B; Ciceri F; Bonini C
    Sci Transl Med; 2022 Feb; 14(631):eabg8027. PubMed ID: 35138911
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bone marrow central memory and memory stem T-cell exhaustion in AML patients relapsing after HSCT.
    Noviello M; Manfredi F; Ruggiero E; Perini T; Oliveira G; Cortesi F; De Simone P; Toffalori C; Gambacorta V; Greco R; Peccatori J; Casucci M; Casorati G; Dellabona P; Onozawa M; Teshima T; Griffioen M; Halkes CJM; Falkenburg JHF; Stölzel F; Altmann H; Bornhäuser M; Waterhouse M; Zeiser R; Finke J; Cieri N; Bondanza A; Vago L; Ciceri F; Bonini C
    Nat Commun; 2019 Mar; 10(1):1065. PubMed ID: 30911002
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Changes in the T-cell receptor V beta gene repertoire after allogeneic hematopoietic stem cell transplantation.
    Liu QF; Li YQ; Yang D; Zhang Y; Yang LJ; Chen SH; Sun J; Liu XL; Zhou SY
    Chin Med J (Engl); 2004 Mar; 117(3):413-8. PubMed ID: 15043783
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Safety and persistence of WT1-specific T-cell receptor gene-transduced lymphocytes in patients with AML and MDS.
    Tawara I; Kageyama S; Miyahara Y; Fujiwara H; Nishida T; Akatsuka Y; Ikeda H; Tanimoto K; Terakura S; Murata M; Inaguma Y; Masuya M; Inoue N; Kidokoro T; Okamoto S; Tomura D; Chono H; Nukaya I; Mineno J; Naoe T; Emi N; Yasukawa M; Katayama N; Shiku H
    Blood; 2017 Nov; 130(18):1985-1994. PubMed ID: 28860210
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Abundant cytomegalovirus (CMV) reactive clonotypes in the CD8(+) T cell receptor alpha repertoire following allogeneic transplantation.
    Link CS; Eugster A; Heidenreich F; Rücker-Braun E; Schmiedgen M; Oelschlägel U; Kühn D; Dietz S; Fuchs Y; Dahl A; Domingues AM; Klesse C; Schmitz M; Ehninger G; Bornhäuser M; Schetelig J; Bonifacio E
    Clin Exp Immunol; 2016 Jun; 184(3):389-402. PubMed ID: 26800118
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bone marrow-derived T-cell clones obtained from untreated acute myelocytic leukemia exhibit blast directed autologous cytotoxicity.
    Jahn B; Bergmann L; Weidmann E; Brieger J; Fenchel K; Schwulera U; Hoelzer D; Mitrou PS
    Leuk Res; 1995 Feb; 19(2):73-82. PubMed ID: 7869744
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Graft γδ TCR Sequencing Identifies Public Clonotypes Associated with Hematopoietic Stem Cell Transplantation Efficacy in Acute Myeloid Leukemia Patients and Unravels Cytomegalovirus Impact on Repertoire Distribution.
    Arruda LCM; Gaballa A; Uhlin M
    J Immunol; 2019 Mar; 202(6):1859-1870. PubMed ID: 30710048
    [TBL] [Abstract][Full Text] [Related]  

  • 16. "Wilms Tumor Protein 1" (WT1) peptide vaccination-induced complete remission in a patient with acute myeloid leukemia is accompanied by the emergence of a predominant T-cell clone both in blood and bone marrow.
    Ochsenreither S; Fusi A; Busse A; Bauer S; Scheibenbogen C; Stather D; Thiel E; Keilholz U; Letsch A
    J Immunother; 2011 Jan; 34(1):85-91. PubMed ID: 21150716
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Single cell T cell landscape and T cell receptor repertoire profiling of AML in context of PD-1 blockade therapy.
    Abbas HA; Hao D; Tomczak K; Barrodia P; Im JS; Reville PK; Alaniz Z; Wang W; Wang R; Wang F; Al-Atrash G; Takahashi K; Ning J; Ding M; Beird HC; Mathews JT; Little L; Zhang J; Basu S; Konopleva M; Marques-Piubelli ML; Solis LM; Parra ER; Lu W; Tamegnon A; Garcia-Manero G; Green MR; Sharma P; Allison JP; Kornblau SM; Rai K; Wang L; Daver N; Futreal A
    Nat Commun; 2021 Oct; 12(1):6071. PubMed ID: 34663807
    [TBL] [Abstract][Full Text] [Related]  

  • 18. T cell receptor gene therapy targeting WT1 prevents acute myeloid leukemia relapse post-transplant.
    Chapuis AG; Egan DN; Bar M; Schmitt TM; McAfee MS; Paulson KG; Voillet V; Gottardo R; Ragnarsson GB; Bleakley M; Yeung CC; Muhlhauser P; Nguyen HN; Kropp LA; Castelli L; Wagener F; Hunter D; Lindberg M; Cohen K; Seese A; McElrath MJ; Duerkopp N; Gooley TA; Greenberg PD
    Nat Med; 2019 Jul; 25(7):1064-1072. PubMed ID: 31235963
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HA-1H T-Cell Receptor Gene Transfer to Redirect Virus-Specific T Cells for Treatment of Hematological Malignancies After Allogeneic Stem Cell Transplantation: A Phase 1 Clinical Study.
    van Balen P; Jedema I; van Loenen MM; de Boer R; van Egmond HM; Hagedoorn RS; Hoogstaten C; Veld SAJ; Hageman L; van Liempt PAG; Zwaginga JJ; Meij P; Veelken H; Falkenburg JHF; Heemskerk MHM
    Front Immunol; 2020; 11():1804. PubMed ID: 32973756
    [TBL] [Abstract][Full Text] [Related]  

  • 20. T cell receptor-engineered T cells derived from target human leukocyte antigen-DPB1-specific T cell can be a potential tool for therapy against leukemia relapse following allogeneic hematopoietic cell transplantation.
    Katsuyama N; Kawase T; Barakat C; Mizuno S; Tomita A; Ozeki K; Nishio N; Sato Y; Kajiya R; Shiraishi K; Takahashi Y; Ichinohe T; Nishikawa H; Akatsuka Y
    Nagoya J Med Sci; 2023 Nov; 85(4):779-796. PubMed ID: 38155626
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.